Metabolic fuel selection: The importance of being flexible

Journal of Clinical Investigation

Volumn 114, Issue 11, 2004, Pages 1547-1549

  Bickel, Perry E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; GLUCOSE TRANSPORTER; MUSCLE PROTEIN; SLC2A4 PROTEIN, MOUSE;

ADIPOCYTE; ENERGY METABOLISM; FATTY ACID OXIDATION; GENETIC DISORDER; GENETIC ENGINEERING; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIVER METABOLISM; METABOLISM; MOUSE STRAIN; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ADIPOSE TISSUE; ANIMAL; GENETICS; HOMEOSTASIS; LIVER; MOUSE; MOUSE MUTANT; NOTE; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; LIVER; MICE; MICE, KNOCKOUT; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL;

EID: 15244340937     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200423745     Document Type: Review

References (19)

1. Shepherd, P.R., and Kahn, B.B. 1999. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341:248-257.
2. Bryant, N.J., Covers, R., and James, D.E. 2002. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 3:267-277.
3. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
4. Kubota, N., et al. 2004. Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus. J. Clin. Invest. 114:917-927. doi:10.1172/JCI200421484.
5. Lin, X., et al. 2004. Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes. J. Clin. Invest. 114:908-916. doi: 10.1172/JCI200422217.
6. Kotani, K., Peroni, O.D., Minokoshi, Y., Boss, O., and Kahn, B.B. 2004. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J. Clin. Invest. 114:1666-1675. doi: 10.1172/JCI200421341.
7. Abel, E.D., et al. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409:729-733.
8. Abel, E.D., et al. 1999. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest. 104:1703-1714.
9. Zisman, A., et al. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6:924-928.
10. Belke, D.D., Larsen, T.S., Gibbs, M., and Severson, D.L. 2000. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am. J. Physiol. Endocrinol. Metab. 279:E1104-E1113.
11. Dentin, R., et al. 2004. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J. Biol. Chem. 279:20314-20326.
12. Laybutt, D.R., et al. 2002. Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J. Biol. Chem. 277:10912-10921.
13. Kelley, D.E., and Mandarine, L.J. 2000. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes. 49:677-683.
14. Basu, A., et al. 2000. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes. 49:272-283.
15. Grimsby, J., et al. 2003. Allosteric activators of glucokinase: potential role in diabetes therapy. Science. 301:370-373.
16. Tomas, E., et al. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U. S. A. 99:16309-16313.
17. Yamauchi, T., et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8:1288-1295.
18. Li, B., et al. 2000. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat. Med. 6:1115-1120.
19. Goodpaster, B.H., Katsiaras, A., and Kelley, D.E. 2003. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes. 52:2191-2197.